• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Microsomal metabolism of triazenylimidazoles.

作者信息

Hill D L

出版信息

Cancer Res. 1975 Nov;35(11 Pt 1):3106-10.

PMID:241485
Abstract

The antitumor agents 5-(3,3-dimethyl-1-triazenyl)imidazole-4-carboxamide (DIC) and 5-[3,3-bis(2-chloroethyl)-1-triazenyl]imidazole-4-carboxamide (BIC) are substrates for NADPH-requiring microsomal enzymes of mouse liver. The products of DIC oxidation are 5-aminoimidazole-4-carboxamide (AIC) and formaldehyde. Those for BIC are AIC and, presumably, 2-chloroacetaldehyde. For DIC, the reaction has a pH optimum of 9.0; and the Michaelis constant (Km) is 0.25 mM. At lower pH values, the Km is not greatly increased; but there is a sharp rise in the Km values above pH 9.0. For the enzyme-catalyzed production of AIC from BIC, the pH optimum is 7.5; the Km value for BIC is 0.47 mM. Of a variety of tissues tested for enzymatic activity, only liver accomplishes the conversion of DIC and BIC to AIC. Most of the activity in the liver is located in the microsomal fraction, although detectable activity is present in washed mitochondria. For liver microsomes, the rate of reaction for BIC is greater than that for DIC, but apparently neither rate is fast enough to allow extensive metabolism of large doses of these agents.

摘要

相似文献

1
Microsomal metabolism of triazenylimidazoles.
Cancer Res. 1975 Nov;35(11 Pt 1):3106-10.
2
Microsomal metabolism of nitrosoureas.亚硝基脲的微粒体代谢
Cancer Res. 1975 Feb;35(2):296-301.
3
Cellular and biochemical aspects of growth retardation in rat fetuses induced by maternal administration of selected anticancer agents.母体给予特定抗癌药物所致大鼠胎儿生长迟缓的细胞和生化方面
Teratology. 1975 Dec;12(3):259-70. doi: 10.1002/tera.1420120307.
4
Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺(NSC-45388)在人和动物肿瘤组织中的代谢
Cancer Chemother Rep. 1972 Aug;56(4):465-72.
5
Observations on the "in vitro" oxidative N-demethylation of 4-(3, 3-dimethyl-1-triazeno)-imidazole-5-carboxamide (DIC, NSC 45388).关于4-(3,3-二甲基-1-三氮烯基)-咪唑-5-甲酰胺(DIC,NSC 45388)的“体外”氧化N-去甲基化的观察
Pharmacol Res Commun. 1976 Feb;8(1):25-9. doi: 10.1016/0031-6989(76)90026-6.
6
Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity.1-(2-氯乙基)-3-烷基-3-(甲基氨基甲酰基)三氮烯的氧化代谢:氯乙醛的形成及其与生物活性的关系
Chem Res Toxicol. 1996 Jan-Feb;9(1):172-8. doi: 10.1021/tx9500639.
7
Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.微粒体谷胱甘肽S-转移酶和细胞色素P450单加氧酶催化抗癌药物1,3-双(2-氯乙基)-1-亚硝基脲的脱亚硝化反应。
Arch Biochem Biophys. 1993 Dec;307(2):369-78. doi: 10.1006/abbi.1993.1602.
8
N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.大鼠和人类对抗肿瘤药物4(5)-(3,3-二甲基-1-三氮烯)咪唑-5(4)-甲酰胺的N-去甲基化作用。
Cancer Res. 1970 Jan;30(1):147-50.
9
Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.新型抗肿瘤药物5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺的处置
J Pharmacol Exp Ther. 1971 Nov;179(2):386-95.
10
[The role of rat liver microsomes in the metabolism of methylmethacrylate to formaldehyde].[大鼠肝微粒体在甲基丙烯酸甲酯代谢为甲醛过程中的作用]
Vopr Med Khim. 1988 Sep-Oct;34(5):14-7.

引用本文的文献

1
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity.肿瘤学中的前药:生物活化及其对治疗效果和毒性的影响。
Int J Mol Sci. 2025 Jan 24;26(3):988. doi: 10.3390/ijms26030988.
2
Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.替莫唑胺和福莫司汀诱导人恶性黑色素瘤细胞凋亡:与O6-甲基鸟嘌呤-DNA甲基转移酶、错配修复、双链断裂和p53相关的反应
Br J Cancer. 2009 Jan 27;100(2):322-33. doi: 10.1038/sj.bjc.6604856. Epub 2009 Jan 6.
3
Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.
达卡巴嗪(DTIC)及其代谢产物5-氨基咪唑-4-甲酰胺(AIC)在不同给药方案后的药代动力学。
Cancer Chemother Pharmacol. 1982;9(2):103-9. doi: 10.1007/BF00265388.
4
N-methyl antitumour agents. A distinct class of anticancer drugs?N-甲基抗肿瘤药物。一类独特的抗癌药物?
Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.